Old Web
English
Sign In
Acemap
>
authorDetail
>
J Preciado Goldaracena
J Preciado Goldaracena
Internal medicine
Medicine
Intensive care medicine
Dose Modification
Surgery
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
4CPS-031 The primary efficacy endpoint for alirocumab, reductions in low-density lipoprotein cholesterol
2019
European Journal of Hospital Pharmacy-Science and Practice
J Polo García
J Preciado Goldaracena
N. Larrea-Goñi
R de la Riva Bohigas
Ja Illodo Becerra
A Rodriguez Esquiroz
M Coma Punset
P Aldave Cobos
B. Larrayoz Sola
M. Sarobe Carricas
Show All
Source
Cite
Save
Citations (0)
4cps-009 efficacy, safety and economic impact of vedolizumab in ulcerative colitis and crohn’s disease
2018
European Journal of Hospital Pharmacy-Science and Practice
J Preciado Goldaracena
J Polo García
Ja Illodo Becerra
M Coma Punset
I Monteserin Garrastatxu
M de Miguel Gaztelu
J Fernández González
A Agulló Fenoll
G Pinilla Lebrero
Me Carrasco del Amo
M. Sarobe Carricas
Show All
Source
Cite
Save
Citations (0)
CP-115 Optimisation of anti-interleukin biological therapies in psoriasis patient above 100 kg
2017
European Journal of Hospital Pharmacy-Science and Practice
J Preciado Goldaracena
N. Larrea-Goñi
M Coma Punset
J Polo García
Ji Yanguas Bayona
C Fontela Bulnes
R San Miguel Elcano
J Fernández González
R Juanbeltz Zurbano
J Alfaro Basarte
Show All
Source
Cite
Save
Citations (0)
DI-046 Analysis of treatment discontinuation by iatrogenesis related to DOLUTEGRAVIR/ABACAVIR/LAMIVUDINE
2017
European Journal of Hospital Pharmacy-Science and Practice
R Juanbeltz Zurbano
A Muñoz San Juan
M. Rivero Marcotegui
J. Repáraz Padrós
M. Gracia-Ruiz de Alda
J Preciado Goldaracena
C Fontela Bulnes
J Polo García
R de la Riva Bohigas
J Alfaro Basarte
Show All
Source
Cite
Save
Citations (0)
1